Skip to main content

Recalled batches of products manufactured by PHARMATHEN INTERNATIONAL

2026-01-07

Product Description :

الاسم التجاري

الاسم العلمي

رقم التسجيل

رقم التشغيلة المتأثرة

الشركة الصانعة

Trade Name

Scientific Name

Register Number

Affected batch number

Manufacturer

Ryxidal 25 mg

RISPERIDONE

2103233397

4400435, 4400888,

PHARMATHEN INTERNATIONAL

Ryxidal 37.5 mg

RISPERIDONE

2103233399

4400436, 4401177, 4401795

Ryxidal 50 mg

RISPERIDONE

2103233398

4400437, 4401796, 4401797

Syngro 20 mg

OCTREOTIDE ACETATE

3010222847

4500329, 4401323

Syngro 30 mg

OCTREOTIDE ACETATE

3010222848

4500285

Issue :

The SFDA has issued a recall for products manufactured by PHARMATHEN INTERNATIONAL due to non-compliance with the approved specifications, following the company’s decision to withdraw the products from the local market.

Recommendations :

For healthcare professionals: Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.

For patients,

  1. Consult your healthcare provider prior to discontinuing use of the batches, or for any health concerns.
  2. Contact the recalling firm or SFDA if you have any questions about the recall.
  3. Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).


Recalled batches of products manufactured by PHARMATHEN INTERNATIONAL